Scilex Holding (SCLX) EBT (2020 - 2026)
Scilex Holding (SCLX) posted quarterly EBT of -$45.6 million for Q1 2026, down 75.04% year-over-year from -$182.9 million in Q1 2025, and up 0.97% quarter-over-quarter from -$46.1 million in Q4 2025.
Scilex Holding (SCLX) EBT (2020 - 2026) Analysis & Trends
Scilex Holding's EBT history runs 7 years deep, the most recent figure standing at -$45.6 million for Q1 2026.
- In Q1 2026, EBT fell 75.04% year-over-year to -$45.6 million; the TTM figure through Mar 2026 stood at -$393.6 million (down 428.24% YoY), while the FY2025 annual figure was -$374.0 million, down 413.72% from the prior year.
- EBT for Q1 2026 stood at -$45.6 million, up from -$46.1 million in the prior quarter.
- The five-year high for EBT was $21.5 million in Q3 2022, with the low at -$257.8 million in Q3 2025.
- The 5-year median for EBT is -$26.1 million (2025), against an average of -$37.1 million.
- Peak annual rise in EBT reached 7732.69% in 2022, while the deepest fall reached 10705.02% in 2022.
- Scilex Holding's EBT stood at -$17.8 million in 2022, then declined by 19.88% to -$21.4 million in 2023, then jumped by 69.8% to -$6.5 million in 2024, then sank by 613.5% to -$46.1 million in 2025, then advanced by 0.97% to -$45.6 million in 2026.
- Business Quant data shows SCLX's EBT at -$45.6 million in Q1 2026, -$46.1 million in Q4 2025, and -$257.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Scilex Holding | 39.35 Mn | -73.44 Mn | 3.97 Mn | -114.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.65 Mn |
| Dec 31, 2025 | -46.10 Mn |
| Sep 30, 2025 | -257.82 Mn |
| Jun 30, 2025 | -44.03 Mn |
| Mar 31, 2025 | -26.08 Mn |
| Dec 31, 2024 | -6.46 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Jun 30, 2024 | -37.58 Mn |
| Mar 31, 2024 | -24.38 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -35.53 Mn |
| Jun 30, 2023 | -26.65 Mn |
| Mar 31, 2023 | -30.75 Mn |
| Dec 31, 2022 | -17.84 Mn |
| Sep 30, 2022 | 21.49 Mn |
| Jun 30, 2022 | -17.87 Mn |
| Mar 31, 2022 | -9.14 Mn |
| Dec 31, 2021 | -46.93 Mn |
| Sep 30, 2021 | -281,552.00 |
| Jun 30, 2021 | -165,349.00 |